Organ Transplant Immunosuppressant Drugs Market Is Expected to Reach US$3.2 B with a CAGR of -5.0% Up to 2023
Transparency Market Research, however, predict bleak growth opportunities for the global organ transplant immunosuppressant drugs market, estimating that the market will exhibit a negative CAGR of -5.0% over the period between 2015 and 2023, dropping to an opportunity of US$3.2 bn by 2023 from a valuation of US$5.1 bn in 2014.
View full press release